Omnia Bio is a technology-focused, global cell and gene therapy CDMO that specializes in manufacturing gene-modified cell therapies and viral vectors. With a strong emphasis on automation and artificial intelligence within a Good Manufacturing Practices (GMP) environment, Omnia Bio offers comprehensive services from preclinical to commercial manufacturing. Strategically located in Hamilton, Ontario, and backed by over a decade of expertise from CCRM, the company is positioned to meet the surging global demand for cell and gene therapy manufacturing. Omnia Bio's focus on immune cell-based therapies, induced pluripotent stem cell therapies, and lentiviral vectors allows it to drive advancements in the field, ensuring that transformative treatments reach patients effectively.
Something looks off?On-site & Remote